Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Fulvestrant × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 116 Neoplasm Metastasis 16 Ovarian Neoplasms 13 Endometrial Neoplasms 9 Neoplasms 8 Triple Negative Breast Neoplasms 5 Prostatic Neoplasms 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Advanced Breast Cancer 4 Neoplasms by Site 3 Hereditary Sensory and Autonomic Neuropathies 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Non-Small-Cell Lung 3 Breast Diseases 3 Breast Cancer Metastatic 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Recurrence 2 Multiple Endocrine Neoplasia Type 1 2 Melanoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Lobular 2 Advanced Solid Tumors 2 Uterine Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Salivary Gland Neoplasms 1

Interventions

Cyclophosphamide 58 Rituximab 47 fludarabine 38 fludarabine phosphate 25 obinutuzumab 17 venetoclax 16 Lenalidomide 16 ibrutinib 15 Etoposide 14 Prednisone 13 pirtobrutinib 12 Whole-Body Irradiation 12 Mycophenolic Acid 11 Melphalan 11 Bendamustine Hydrochloride 11 Tacrolimus 10 Specimen Handling 10 Filgrastim 10 Doxorubicin 10 Biopsy 10 Vincristine 9 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 pembrolizumab 8 Stem Cell Transplantation 8 Peripheral Blood Stem Cell Transplantation 8 Nivolumab 8 Gemcitabine 8 Cytarabine 8 tocilizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡